智飞生物（300122）8月5日主力资金净流出3161.16万元

Core Insights - The stock price of Zhifei Biological (300122) closed at 24.08 yuan on August 5, 2025, with a 0.75% increase and a turnover rate of 3.36% [1] - The company reported a significant decline in revenue and profit for Q1 2025, with total revenue of 2.374 billion yuan, a year-on-year decrease of 79.16%, and a net profit of 305.14 million yuan, down 120.93% [1] Financial Performance - Total revenue for Q1 2025: 2.374 billion yuan, down 79.16% year-on-year [1] - Net profit for Q1 2025: 305.14 million yuan, down 120.93% year-on-year [1] - Non-recurring net profit: 319.66 million yuan, down 121.97% year-on-year [1] - Current ratio: 2.298, quick ratio: 1.029, debt-to-asset ratio: 36.85% [1] Market Activity - Main funds experienced a net outflow of 31.61 million yuan, accounting for 2.76% of the transaction amount [1] - Large orders saw a net outflow of 23.67 million yuan, representing 2.06% of the transaction amount [1] - Small orders had a net inflow of 42 million yuan, making up 3.66% of the transaction amount [1] Company Background - Zhifei Biological was established in 1995 and is located in Chongqing, primarily engaged in the pharmaceutical manufacturing industry [2] - The company has a registered capital of 2.393 billion yuan and a paid-in capital of 400 million yuan [1][2] - The legal representative of the company is Jiang Rensheng [1]